Is it worth buying Rentokil Initial stock at a price of $39.83? If this question is on your mind, make sure to check out the fundamentals of this Business Services Large-Cap company:
-
Rentokil Initial has logged a 21.7% 52 week change, compared to -1.5% for the S&P 500
-
RTO has an average analyst rating of buy and is -0.45% away from its mean target price of $40.01 per share
-
Its trailing earnings per share (EPS) is $0.73, which brings its trailing Price to Earnings (P/E) ratio to 54.6. The Consumer Discretionary sector's average P/E ratio is 22.33
-
The company has a Price to Book (P/B) ratio of 4.86 in contrast to the Consumer Discretionary sector's average P/B ratio is 3.12
-
The current ratio is currently 1.1, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
RTO has reported YOY quarterly earnings growth of -35.4% and gross profit margins of 0.8%
-
The company's free cash flow for the last fiscal year was $410.0 Million and the average free cash flow growth rate is 8.9%
-
Rentokil Initial's revenues have an average growth rate of 8.2% with operating expenses growing at inf%. The company's current operating margins stand at 9.2%